[Contribution to the combined treatment of irido-ciliary tuberculoma].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004194:Disease; D007499:Iris Diseases; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014375:Tuberculoma / Q000628:therapy*; D014602:Uvea
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
IRIS/diseases; NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOMA/therapy; UVEA/diseases
Contribution au traitement combiné d'un tuberculome irido-ciliaire.